Skip to content

Anogenital HPV infection and related neoplasia among women living with HIV in Yunnan, China: a prospective cohort study

Anogenital HPV infection and related neoplasia among women living with HIV in Yunnan, China: a prospective cohort study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400091461
Enrollment
Unknown
Registered
2024-10-29
Start date
2024-11-01
Completion date
Unknown
Last updated
2025-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer/ HPV-associated anogenital tract tumors

Interventions

General woman:No intervention
Woman living with HIV:No intervention

Sponsors

Yunnan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) HIV-1 seropositive and with ongoing cART; 2) age 18 years or older; 3) history of sexual activity; 4) physically and mentally able to undergo cervical and anal sampling; 5) cervix intact and not currently pregnant.

Exclusion criteria

Exclusion criteria: 1) Have previously received the HPV vaccine; 2) Have had cervical or anal surgery within the past 3 months.

Design outcomes

Primary

MeasureTime frame
HPV infection status ; Immune- related factor ;Reproductive tract microflora;Results of medical examination;cervical and anal HPV infection rates;Persistent rates of cervical and anal HPV infection;6 months cervical and anal HPV clearance ;Cervical and anal HPV 12 months clearance;Cervical and anal HPV clearance at 18 months;Cervical and anal HPV 24 month clearance ;Risk factors for persistent HPV infection;

Countries

China

Contacts

Public ContactZhang Hongping / Duan Rufei

Yunnan Cancer Hospital

kmzhp@126.com+86 187 2515 2045

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026